Previous Meetings

GBCC 2013

Global Breast Cancer Conference 2013

09:00-10:00
Plenary Lecture I
Venue: Vista I+II
  • Personalized Therapy in Era of Molecular Diagnosis
    Nancy E. Davidson (Univ. of Pittsburgh Cancer Institute, U.S.A.)
10:10-11:20
Symposium I
Surveillance of DCIS
Venue: Vista I+II
  • Recurrence Predictive Markers for DCIS
    Gary Tse (Prince of Wales Hospital, Hong Kong)
  • Imaging Controversy in DCIS Surveillance
    Hee Jung Shin (ASAN Medical Center, Korea)
  • Scanxiety: Controling Fear of Cancer
    Juhee Cho (Samsung Comprehensive Cancer Center, Korea)
Symposium II
Breast Cancer Prevention and Epidemiology
Venue: Vista III
  • Breast Cancer Epidemiology among Asians: Heterogeneity by Country, Age and Race/Ethnicity
    Yeonju Kim (Univ. of Hawaii Cancer Center, U.S.A.)
  • Lifestyle Factors and Breast Cancer (BC) Risk
    Pamela Goodwin (Samuel Lunenfeld Research Institute at Mount Sinai Hospital, Canada)
  • Public Health Surveillance and Breast Cancer Prevention Agenda
    Insun Kim (Centers for Disease Control and Prevention, U.S.A.)
11:20-12:30
Symposium III
Breast Cancer Management Issues in Clinical Practice as an Oncologist
Venue: Vista I+II
  • Discrepancies between Ideals and Reality in Korea
    Kyung Hae Jung (ASAN Medical Center, Korea)
  • Neoadjuvant Therapy for Early Breast Cancer in HER2 Type and Luminal Type Tumors
    Hirotaka Iwase (Kumamoto Univ., Japan)
  • Challenges of the “Second Wave” of Personalized Medicine – The Hong Kong Bedside Experience
    Janice Tsang (Queen Mary Hospital, The Univ. of Hong Kong, Hong Kong)
  • Breast Cancer Management Issues in the Clinic as an Oncologist? Cases from Malaysia
    Cheng Har Yip (Sime Darby Medical Centre, Subang Jaya, Malaysia)
Panel Session I
Role of Preoperative MRI in Breast Cancer
Venue: Vista III
  • Pros: Role of Preoperative MRI in Breast Cancer
    Min Jung Kim (Yonsei Univ. Severance Hospital, Korea)
  • Cons: Breast MRI, Minimizing Potential Harms
    Hyeong-Gon Moon (Seoul National Univ. Hospital, Korea)
12:30-13:30
Luncheon Symposium
Venue: Vista I+II
  • Efficacy and Safety of Chemo/Radio Therapy Combined with Mistletoe in Breast Cancer
    Anette Voigt (Gemeinschaftskrankenhaus Herdecke, Germany)
13:30-15:00
Free Paper Session I
Risk and Prevention / Detection and Diagnosis
Venue: Vista I+II
  • ATTITUDE TOWARDS PERFORMING BREAST SELF-EXAMINATION (BSE) AMONG FEMALE UNDERGRADUATES IN HONG KONG
    Chung Yin Joyce Leung (The Open Univ. of Hong Kong, Hong Kong)
  • MAMMOGRAPHIC DENSITY AS A BREAST CANCER RISK PREDICTOR ASSOCIATED WITH ESTRADIOL LEVEL AND BODY MASS INDEX IN INDONESIAN WOMEN
    Lina Choridah (Faculty of Medicine Universitas Gadjah Mada, Indonesia)
  • MAGNETIC RESONANCE IMAGING FINDING OF TRIPLE NEGATIVE BREAST CANCER
    Sun Hyoung Shin (Chonnam National Univ. Hwasun Hospital, Korea)
  • TIME INTERVAL FROM DIAGNOSIS TO TREATMENT IN INVASIVE BREAST CANCER PATIENTS
    Haeseong Park (Virginia Commonwealth Univ., U.S.A.)
  • MODIFIED TECHNIQUE OF RADIOTRACER INJECTION FOR THE HIGH VISUALIZATION OF INTERNAL MAMMARY SENTINEL LYMPH NODE IN BREAST DIAGNOSTIC PROCEDURES: PROSPECTIVE STUDY WITH CREDIBLE RESULTS
    Yongsheng Wang (Shandong Cancer Hospital and Institute, China)
  • INTRAOPERATIVE FROZEN SECTION ANALYSIS FOR MARGINS ASSESSMENT IN BREAST CONSERVING SURGERY
    Min Jung Hwang (Chonnam National Univ. Hwasun Hospital, Korea)
  • CLINICAL BENEFITS OF USING NOMOGRAM FOR PREDICTING POSITIVE RESECTION MARGINS IN BREAST CONSERVING SURGERY
    Eunshin Lee (Seoul National Univ., Korea)
  • CLINICOPATHOLOGICAL STUDY OF BREAST MUCINOUS CARCINOMA SUB-CLASSIFICATION
    Yuka Asano (Graduate School of Medicine, Osaka City Univ., Japan)
  • BODY SIZE AND WEIGHT MANAGEMENT AMONG LONG TERM CANCER SURVIVORS: PERSPECTIVES FROM CLINICAL CARE PROVIDERS
    Ann C. Klassen (Drexel Univ. School of Public Health, U.S.A.)
Free Paper Session II
Tumor and Cell Biology
Venue: MGB I
  • IN UTERO EXPOSURE TO DIETARY LIPOTROPES SUPPRESSES CHEMICALLY-INDUCED MAMMARY CARCINOGENESIS
    Chung Park (North Dakota State Univ., U.S.A.)
  • CASPASE-2 PLAYS A KEY ROLE IN CELL DEATH INDUCTION BY TAXANES IN BREAST CANCER CELLS
    Jan Kovar (Third Faculty of Medicine, Charles Univ., Czech Republic)
  • MET IS A POTENTIAL TARGET FOR USE IN COMBINATION THERAPY WITH EGFR INHIBITION IN TRIPLE-NEGATIVE/BASAL-LIKE BREAST CANCER
    Yu Jin Kim (Samsung Medical Center, Korea)
  • HISTONE DEACETYLASES INHIBITOR SAHA ENHANCES ANTI-TUMOR EFFECTS OF POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITOR OLAPARIB IN TRIPLE-NEGATIVE BREAST CANCER CELLS
    Ahrum Min (College of Medicine, Seoul National Univ., Korea)
  • HISTONE DEACETYLASES INHIBITOR SAHA ENHANCES ANTI-TUMOR EFFECTS OF POLY (ADP-RIBOSE) POLYMERASE INHIBITOR OLAPARIB IN TRIPLE-NEGATIVE BREAST CANCER CELLS
    Ser Yue Loo (National Univ. of Singapore, Singapore)
  • EXTENSIVE NOVEL HYBRID ISOFORMS REVEALED BY RNA SEQUENCING OF 120 PRIMARY BREAST CANCER SAMPLES
    Jisun Kim (Seoul National Univ. Hospital, Korea)
  • REDUCTION OF BREAST CANCER RELAPSES WITH PERIOPERATIVE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS: PERHAPS TRANSIENT SYSTEMIC INFLAMMATION POST SURGERY PRECIPITATES METASTATIC ACTIVITY
    Michael Retsky (Harvard School of Public Health, U.S.A.)
  • INFLUENCE OF CD44 GENE POLYMORPHISMS IN BREAST CANCER PROGNOSIS
    Sonam Tulsyan (Sanjay Gandhi Postgraduate Institute of Medical Science, India)
  • PROGNOSTIC IMPACT OF YB-1 IN BREAST CANCER
    Anbok Lee (Ewha Womans Univ. Hospital, Korea)
15:20-16:30
Education Session I
Cancer Genomics I
Venue: MGB II
  • Genome-wide Profiling of Breast Cancer: History and Lessons from Studies before NGS Era
    Wonshik Han (Seoul National Univ. Hospital, Korea)
  • Introduction of Next Generation Sequencing and Its Clinical Implication
    Se-Hoon Lee (Seoul National Univ. Hospital, Korea)
  • Genomic Portrait of Breast Cancer
    Matthew J. Ellis (Washington Univ., U.S.A.)
15:20-17:40
Insight GBCC I
Multidisciplinary Approach for Young Age Breast Cancer
Venue: MGB I
  • Is the Age of the Patients a Contraindicating Factor to Breast Conservation?
    Toru Watanabe (Hamamatsu Oncology Center, Japan)
  • Pregnancy Associated Breast Cancer
    Hyun Jo Youn (Chonbuk National Univ. Hospital, Korea)
  • Fertility Preservation for Early Breast Cancer: Medical Oncologist's Perspectives
    Ann H. Partridge (Dana-Farber Cancer Institute, U.S.A.)
  • Culturally-sensitive Health Promotion Program on Breast Cancer for Ethnic Minority Women
    Carmen Wing Han Chan (The Chinese Univ. of Hong Kong, Hong Kong)
  • Preservation of Ovarian Function in Young Age Breast Cancer
    DooSeok Choi (Samsung Medical Center, Korea)
  • Psychiatric Consultation and Psychosocial Intervention for Young Age Breast Cancer
    Seong-Jin Cho (Korea Cancer Center Hospital, Korea)
16:30-17:40
Symposium IV
Refining Local Treatment of Breast Cancer
Venue: MGB II
  • Prediction of Local Recurrence on Preoperative MRI
    Nariya Cho (Seoul National Univ. Hospital, Korea)
  • Surgical Issues according to the Breast Cancer Subtypes
    Woochul Noh (Korea Cancer Center Hospital, Korea)
  • Radiotherapy after Breast Reconstruction
    Su Ssan Kim (ASAN Medical Center, Korea)
Back to Previous Meetings